COLL logo

Collegium Pharmaceutical (COLL) CAPEX

Annual CAPEX

$461.00 K
-$1.16 M-71.58%

December 31, 2023

Summary

Performance

1-Year Change

-71.58%

3-Year Change

-99.88%

5-Year Change

-98.11%

15-Year Change

-53.43%

COLL CAPEX Chart

Add series to chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Highlights

Sector Rank

26.6%
COLL annual capital expenditures is higher than 26.6% of companies in Healthcare sector

High & Low

All-time High

$373.77 M
COLL annual capital expenditures is currently -99.88% below its historical high of $373.77 million

3-Year Low

$461.00 K
COLL annual capital expenditures is currently at its 3-year low

Earnings dates

Last Annual Earnings Report Date

Dec 31, 2023
COLL previous annual earnings announcement was published on Dec 31, 2023

Next Annual Earnings Report Date

Feb 21, 2025
COLL next annual earnings announcement is scheduled for Feb 21, 2025

OtherCOLLcash flowmetrics:

Annual FCF

$274.29 M
COLL annual free cash flow is $274.29 million

Annual CFO

$274.75 M
COLL annual cash flow from operations is $274.75 million

Annual CFI

-$70.81 M
COLL annual cash flow from investing activities is -$70.81 million

Annual CFF

-$140.18 M
COLL annual cash flow from financing activities is -$140.18 million

Quarterly CAPEX

$244.00 K
-$26.00 K-9.63%

September 30, 2024

Summary

Performance

3-Month Change

-9.63%

1-Year Change

+275.38%

3-Year Change

+275.38%

5-Year Change

+275.38%

COLL Quarterly CAPEX Chart

Add series to chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Highlights

Sector Rank

38.68%
COLL quarterly capital expenditures is higher than 38.68% of companies in Healthcare sector

High & Low

All-time High

$367.65 M
COLL quarterly capital expenditures is currently -99.93% below its historical high of $367.65 million

3-Year Low

$56.00 K
COLL quarterly capital expenditures is currently +335.71% above its 3-year low

Earnings dates

Last Quarterly Earnings Report Date

Sep 30, 2024
COLL previous earnings announcement was published on Sep 30, 2024

Next Quarterly Earnings Report Date

Feb 21, 2025
COLL next earnings announcement is scheduled for Feb 21, 2025

OtherCOLLcash flowmetrics:

Quarterly FCF

-$9.24 M
COLL quarterly free cash flow is -$9.24 million

Quarterly CFO

-$9.00 M
COLL quarterly cash flow from operations is -$9.00 million

Quarterly CFI

-$248.96 M
COLL quarterly cash flow from investing activities is -$248.96 million

Quarterly CFF

$149.03 M
COLL quarterly cash flow from financing activities is $149.03 million

TTM CAPEX

$1.25 M
+$179.00 K+16.78%

September 30, 2024

Summary

Performance

3-Month Change

+16.78%

1-Year Change

+0.73%

3-Year Change

+0.73%

5-Year Change

+0.73%

COLL TTM CAPEX Chart

Add series to chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Highlights

Sector Rank

38.09%
COLL TTM capital expenditures is higher than 38.09% of companies in Healthcare sector

High & Low

All-time High

$373.77 M
COLL TTM capital expenditures is currently -99.67% below its historical high of $373.77 million

3-Year Low

$461.00 K
COLL TTM capital expenditures is currently +170.28% above its 3-year low

Earnings dates

Last Quarterly Earnings Report Date

Sep 30, 2024
COLL previous earnings announcement was published on Sep 30, 2024

Next Quarterly Earnings Report Date

Feb 21, 2025
COLL next earnings announcement is scheduled for Feb 21, 2025

OtherCOLLcash flowmetrics:

TTM FCF

$192.43 M
COLL TTM free cash flow is $192.43 million

TTM CFO

$193.67 M
COLL TTM cash flow from operations is $193.67 million

TTM CFI

-$301.09 M
COLL TTM cash flow from investing activities is -$301.09 million

TTM CFF

-$87.15 M
COLL TTM cash flow from financing activities is -$87.15 million

COLL CAPEX Trends

PeriodPeriodAnnualAnnualQuarterlyQuarterlyTTMTTM
1 y1 year-71.6%+275.4%+0.7%
3 y3 years-99.9%+275.4%+0.7%
5 y5 years-98.1%+275.4%+0.7%

COLL CAPEX Highs & Lows

PeriodPeriodAnnual vs highAnnual vs highAnnual vs lowAnnual vs lowQuarter. vs highQuarter. vs highQuarter. vs lowQuarter. vs lowTTM vs highTTM vs highTTM vs lowTTM vs low
3 y3-year-76.3%at low-74.0%+335.7%-35.9%+170.3%
5 y5-year-99.9%at low-99.9%+335.7%-99.7%+170.3%
alltimeall time-99.9%at low-99.9%+741.4%-99.7%+1022.5%

Collegium Pharmaceutical CAPEX History

DateAnnualQuarterlyTTM
Sep 2024
-
$244.00 K(-9.6%)
$1.25 M(+16.8%)
Jun 2024
-
$270.00 K(-52.5%)
$1.07 M(+25.1%)
Mar 2024
-
$568.00 K(+246.3%)
$853.00 K(+85.0%)
Dec 2023
$461.00 K(-71.6%)
$164.00 K(+152.3%)
$461.00 K(-62.7%)
Sep 2023
-
$65.00 K(+16.1%)
$1.24 M(-3.7%)
Jun 2023
-
$56.00 K(-68.2%)
$1.28 M(-24.0%)
Mar 2023
-
$176.00 K(-81.3%)
$1.69 M(+4.2%)
Dec 2022
$1.62 M(-16.6%)
$940.00 K(+731.9%)
$1.62 M(+35.5%)
Sep 2022
-
$113.00 K(-75.5%)
$1.20 M(-12.0%)
Jun 2022
-
$461.00 K(+326.9%)
$1.36 M(-16.3%)
Mar 2022
-
$108.00 K(-79.0%)
$1.62 M(-16.5%)
Dec 2021
$1.94 M(-99.5%)
$515.00 K(+86.6%)
$1.94 M(-33.2%)
Sep 2021
-
$276.00 K(-61.9%)
$2.91 M(-42.2%)
Jun 2021
-
$725.00 K(+69.4%)
$5.04 M(-23.1%)
Mar 2021
-
$428.00 K(-71.1%)
$6.55 M(-98.2%)
Dec 2020
$373.77 M
$1.48 M(-38.4%)
$373.77 M(+0.2%)
DateAnnualQuarterlyTTM
Sep 2020
-
$2.40 M(+7.2%)
$373.18 M(+0.3%)
Jun 2020
-
$2.24 M(-99.4%)
$372.13 M(+0.4%)
Mar 2020
-
$367.65 M(>+9900.0%)
$370.76 M(+5659.0%)
Dec 2019
$6.44 M(-73.6%)
$889.00 K(-34.2%)
$6.44 M(-12.1%)
Sep 2019
-
$1.35 M(+54.4%)
$7.32 M(-15.7%)
Jun 2019
-
$875.00 K(-73.7%)
$8.69 M(+1.5%)
Mar 2019
-
$3.32 M(+87.4%)
$8.56 M(-64.9%)
Dec 2018
$24.35 M(+2360.0%)
$1.77 M(-34.7%)
$24.35 M(+7.0%)
Sep 2018
-
$2.72 M(+263.7%)
$22.75 M(+11.7%)
Jun 2018
-
$747.00 K(-96.1%)
$20.38 M(+1.5%)
Mar 2018
-
$19.12 M(>+9900.0%)
$20.08 M(+1928.1%)
Dec 2017
$990.00 K(-66.7%)
$172.00 K(-49.4%)
$990.00 K(-14.6%)
Sep 2017
-
$340.00 K(-24.3%)
$1.16 M(+24.6%)
Jun 2017
-
$449.00 K(+1448.3%)
$930.00 K(+93.3%)
Mar 2017
-
$29.00 K(-91.5%)
$481.00 K(+6.4%)
Dec 2016
$2.98 M
$341.00 K(+207.2%)
$452.00 K(+307.2%)
Sep 2016
-
$111.00 K
$111.00 K

FAQ

  • What is Collegium Pharmaceutical annual capital expenditures?
  • What is the all time high annual CAPEX for Collegium Pharmaceutical?
  • What is Collegium Pharmaceutical annual CAPEX year-on-year change?
  • What is Collegium Pharmaceutical quarterly capital expenditures?
  • What is the all time high quarterly CAPEX for Collegium Pharmaceutical?
  • What is Collegium Pharmaceutical quarterly CAPEX year-on-year change?
  • What is Collegium Pharmaceutical TTM capital expenditures?
  • What is the all time high TTM CAPEX for Collegium Pharmaceutical?
  • What is Collegium Pharmaceutical TTM CAPEX year-on-year change?

What is Collegium Pharmaceutical annual capital expenditures?

The current annual CAPEX of COLL is $461.00 K

What is the all time high annual CAPEX for Collegium Pharmaceutical?

Collegium Pharmaceutical all-time high annual capital expenditures is $373.77 M

What is Collegium Pharmaceutical annual CAPEX year-on-year change?

Over the past year, COLL annual capital expenditures has changed by -$1.16 M (-71.58%)

What is Collegium Pharmaceutical quarterly capital expenditures?

The current quarterly CAPEX of COLL is $244.00 K

What is the all time high quarterly CAPEX for Collegium Pharmaceutical?

Collegium Pharmaceutical all-time high quarterly capital expenditures is $367.65 M

What is Collegium Pharmaceutical quarterly CAPEX year-on-year change?

Over the past year, COLL quarterly capital expenditures has changed by +$179.00 K (+275.38%)

What is Collegium Pharmaceutical TTM capital expenditures?

The current TTM CAPEX of COLL is $1.25 M

What is the all time high TTM CAPEX for Collegium Pharmaceutical?

Collegium Pharmaceutical all-time high TTM capital expenditures is $373.77 M

What is Collegium Pharmaceutical TTM CAPEX year-on-year change?

Over the past year, COLL TTM capital expenditures has changed by +$9000.00 (+0.73%)